Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer
Lung Cancer Sep 14, 2017
Kato T, et al. - This study reported the use of novel porphyrin-lipid nanoparticles (porphysomes) targeted to folate receptor 1 (FOLR1) to enhance the efficacy and specificity of photodynamic therapy (PDT). In selectively ablating lung cancer based on FOLR1 expression in these preclinical models, folate-porphysome based PDT showed promise.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
